Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
Hellenic J Cardiol. 2019 Jul-Aug;60(4):211-215. doi: 10.1016/j.hjc.2019.01.001. Epub 2019 Jan 9.
The management of ST-segment elevation myocardial infarction (STEMI) has evolved significantly over the last decades. STEMI treatment includes reperfusion therapy, ideally by primary percutaneous coronary intervention (pPCI), modern antithrombotic therapy and secondary prevention measures. Even though many areas in the management of STEMI are well studied and analyzed in the guidelines, there are still challenges and unanswered questions on how to improve outcomes. This review aims to offer an insight in areas that need to be explored.
急性 ST 段抬高型心肌梗死(STEMI)的管理在过去几十年中发生了重大变化。STEMI 的治疗包括再灌注治疗,理想的方法是通过直接经皮冠状动脉介入治疗(pPCI)、现代抗血栓治疗和二级预防措施。尽管指南中对 STEMI 的许多管理领域进行了深入研究和分析,但在如何改善预后方面仍存在挑战和未解决的问题。本文旨在提供需要探讨的领域的见解。